Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study

Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study

Item

http://www.wikidata.org/entity/Q36554725

Q36554725

about

Genomic profiling in luminal breast cancer Medical factors influencing decision making regarding radiation therapy for breast cancer Microarray based analysis of gene regulation by mesenchymal stem cells in breast cancer Long term outcomes reporting the safety of breast conserving therapy compared to mastectomy: 20-year results of EORTC 10801 The 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.Comparison of plan optimization for single and dual volumetric-modulated arc therapy versus intensity-modulated radiation therapy during post-mastectomy regional irradiation.The 21-gene recurrence score and locoregional recurrence in breast cancer patients.Ductal carcinoma in situ: an overview.Cancer biomarker discovery: current status and future perspectives.Is mastectomy undertreatment for low-risk breast cancers eligible for breast-conserving therapy?21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.Breast Cancer Clinical Trials: Past Half Century Moving Forward Advancing Patient Outcomes.Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers.Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.The Era of Multigene Panels Comes? The Clinical Utility of Oncotype DX and MammaPrint.Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.Gene Expression Profiling in Breast Cancer and Its Effect on Therapy Selection in Early-Stage Breast Cancer

P2860

Q26862681-15BA5EFE-FCE8-4A15-A3BF-6B59EB72AB1B Q27005934-5ABBE453-754E-44F3-891B-478F6F9A1623 Q33599142-AE81583E-33C1-46C7-AF0E-21EB118B45B1 Q33973090-24BA74DF-AD57-4F71-A9C6-8415AFB15446 Q35054821-B88A6714-F9F6-48F1-BEEC-8AB027AF69CA Q36826003-B63F2438-FEEE-4459-968B-D1ABA82955C6 Q36908670-A7C12B76-0FFB-4F95-82A9-E481F8368F8B Q38132242-E397E081-DE18-4C25-B9A9-3F8CD53075E6 Q38187679-7AEDC3D9-BC78-4628-A38A-8E515CA87FAE Q38446546-35EC433A-AFB5-41FF-8C17-A3CB83746EE5 Q38681547-F749CBD9-0E09-4DF7-9088-CC5F2DD56DF0 Q38882550-0B9395B9-5184-4F8B-8E61-6E8C582B9B1D Q45943755-211BA130-4198-4A1B-9168-7DD93266C821 Q47204606-13517BD0-8E29-4C99-8D83-52E42689F49A Q47835415-AA9C1DEE-8756-490E-B8FE-D902CBC559D6 Q50610834-D14E00DE-588D-4C63-89F1-D6F42AC7CB84 Q51168829-BDF73961-6215-4584-8468-F7DDBD19E578 Q57116157-6F0A0BBB-7A9A-44C8-9F58-ACF75D09FA49

P2860

Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study

Item

http://www.wikidata.org/entity/Q36554725

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Prognostic value of biologic s ...... ive Oncology Group E2197 study

@ast

Prognostic value of biologic s ...... ive Oncology Group E2197 study

@en

type

Item

label

Prognostic value of biologic s ...... ive Oncology Group E2197 study

@ast

Prognostic value of biologic s ...... ive Oncology Group E2197 study

@en

prefLabel

Prognostic value of biologic s ...... ive Oncology Group E2197 study

@ast

Prognostic value of biologic s ...... ive Oncology Group E2197 study

@en

P1476

Prognostic value of biologic s ...... ive Oncology Group E2197 study

@en

P2093

Abram Recht

http://www.w3.org/2001/XMLSchema#string

Edith A Perez

http://www.w3.org/2001/XMLSchema#string

Frederick L Baehner

http://www.w3.org/2001/XMLSchema#string

George W Sledge

http://www.w3.org/2001/XMLSchema#string

Joseph A Sparano

http://www.w3.org/2001/XMLSchema#string

Lawrence J Solin

http://www.w3.org/2001/XMLSchema#string

Lawrence N Shulman

http://www.w3.org/2001/XMLSchema#string

Lori J Goldstein

http://www.w3.org/2001/XMLSchema#string

Nancy E Davidson

http://www.w3.org/2001/XMLSchema#string

Robert Gray

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation.

Triple-negative breast cancer: clinical features and patterns of recurrence.

Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.

Nodal status and clinical outcomes in a large cohort of patients with triple-negative breast cancer.

Predicting a local recurrence after breast-conserving therapy by gene expression profiling.

Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer

The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy.

P2888

s10549-012-2072-y

P304

683-692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-012-2072-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22547108

http://www.w3.org/2001/XMLSchema#string

P932

3552372

http://www.w3.org/2001/XMLSchema#string

Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study

about

P2860

P2860

Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P932